ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
CBSL |
P0DN79 P35520
|
cystathionine beta-synthase like
|
|
|
0.540 |
0.808 |
MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
HOXA@ |
|
homeobox A cluster
|
|
|
0.599 |
0.654 |
HOXD@ |
|
homeobox D cluster
|
|
|
0.631 |
0.538 |
HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
HOXC@ |
|
homeobox C cluster
|
|
|
0.695 |
0.462 |
DVL1P1 |
P54792
|
dishevelled segment polarity protein 1 pseudogene 1
|
Signaling
|
|
0.716 |
0.423 |
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
ABCC2 |
Q92887
|
ATP binding cassette subfamily C member 2
|
Transporter
|
5.2E-47 |
0.483 |
0.808 |
CUBN |
O60494
|
cubilin
|
|
4.6E-42 |
0.587 |
0.769 |
FANCI |
Q9NVI1
|
FA complementation group I
|
|
8.9E-37 |
0.543 |
0.731 |
FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
FAP |
Q12884
|
fibroblast activation protein alpha
|
Enzyme
|
1.9E-28 |
0.496 |
0.808 |
PKD2L1 |
Q9P0L9
|
polycystin 2 like 1, transient receptor potential cation channel
|
Ion channel
|
1.6E-27 |
0.565 |
0.731 |
BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
FANCL |
Q9NW38
|
FA complementation group L
|
Enzyme
|
5.9E-23 |
0.551 |
0.731 |
SLX4 |
Q8IY92
|
SLX4 structure-specific endonuclease subunit
|
|
1.6E-22 |
0.565 |
0.731 |
ERCC2 |
P18074
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
Enzyme
|
7.1E-20 |
0.420 |
0.846 |
PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |